Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis
-
* Corresponding author: M Matucci Cerinic cerinic@unifi.it
Arthritis Research & Therapy 2005, 7:R1244-R1253 doi:10.1186/ar1815